Literature DB >> 8902566

Two regions of homozygosity on chromosome 3p in squamous cell carcinoma of the head and neck: comparison with cytogenetic analysis.

D L Buchhagen1, M J Worsham, D L Dyke, T E Carey.   

Abstract

BACKGROUND: Loss effecting the short arm of chromosome 3 occurs in nearly 60% of squamous cell carcinomas of the head and neck (SCCHN). Karyotype analysis indicated that these losses occur in two regions, 3p13-p14 and 3p21-p24. To test these findings, we examined tumor DNA from 38 SCCHN cell lines for heterozygosity and homozygosity at 6 polymorphic loci spanning this region.
METHODS: The polymerase chain reaction (PCR) was used to amplify polymorphic restriction sites on 3p, the amplified products were digested with the appropriate restriction enzyme, electrophoresed on agarose gels, and assessed for the presence of one or both alleles. The 38 SCCHN cell lines were established from 31 patients and included 16 that had been karyotyped. In 6 cases two or three tumor cell lines established from separate tumors in the same patients were studied.
RESULTS: The cell lines exhibited a very low frequency of heterozygosity for the regions 3p12-3p21 (D3S3, D3S30 and D3S2) and distal 3p21-3p24 (D3F15S2 and THRB), when compared with that observed in the normal population. In contrast, D3S32, located within 3p21, was heterozygous in 38% of the tumors which is close to the frequency seen in the normal population (50%). In most cases the PCR results were consistent with the cytogenetic predictions. However, in 4 cell lines 3p loss was predicted from the karyotype, but heterozygosity for D3S32 was present.
CONCLUSIONS: These experiments support cytogenetic data that indicate two regions of 3p loss in SCCHN tumors. The 3p regions that show a high frequency of homozygosity may contain tumor suppressor genes involved in the development and/or progression of squamous cancer. The region surrounding D3S32 may contain an essential gene that is conserved in two copies even when much of 3p is lost.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8902566     DOI: 10.1002/(SICI)1097-0347(199611/12)18:6<529::AID-HED7>3.0.CO;2-4

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  8 in total

1.  The influence of clinical and demographic risk factors on the establishment of head and neck squamous cell carcinoma cell lines.

Authors:  Jason S White; Joel L Weissfeld; Camille C R Ragin; Karen M Rossie; Christa Lese Martin; Michele Shuster; Chandramohan S Ishwad; John C Law; Eugene N Myers; Jonas T Johnson; Susanne M Gollin
Journal:  Oral Oncol       Date:  2006-11-16       Impact factor: 5.337

2.  Molecular characterization of head and neck cancer: how close to personalized targeted therapy?

Authors:  Maria J Worsham; Haythem Ali; Jadranka Dragovic; Vanessa P Schweitzer
Journal:  Mol Diagn Ther       Date:  2012-08-01       Impact factor: 4.074

3.  Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screening.

Authors:  A K El-Naggar; L Mao; G Staerkel; M M Coombes; S L Tucker; M A Luna; G L Clayman; S Lippman; H Goepfert
Journal:  J Mol Diagn       Date:  2001-11       Impact factor: 5.568

4.  Predicting PD-L1 expression on human cancer cells using next-generation sequencing information in computational simulation models.

Authors:  Emily A Lanzel; M Paula Gomez Hernandez; Amber M Bates; Christopher N Treinen; Emily E Starman; Carol L Fischer; Deepak Parashar; Janet M Guthmiller; Georgia K Johnson; Taher Abbasi; Shireen Vali; Kim A Brogden
Journal:  Cancer Immunol Immunother       Date:  2016-09-29       Impact factor: 6.968

5.  Radiation-Induced Dedifferentiation of Head and Neck Cancer Cells Into Cancer Stem Cells Depends on Human Papillomavirus Status.

Authors:  Erina Vlashi; Allen M Chen; Sabrina Boyrie; Garrett Yu; Andrea Nguyen; Philip A Brower; Clayton B Hess; Frank Pajonk
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-01-14       Impact factor: 7.038

6.  Computational Models Accurately Predict Multi-Cell Biomarker Profiles in Inflammation and Cancer.

Authors:  Carol L Fischer; Amber M Bates; Emily A Lanzel; Janet M Guthmiller; Georgia K Johnson; Neeraj Kumar Singh; Ansu Kumar; Robinson Vidva; Taher Abbasi; Shireen Vali; Xian Jin Xie; Erliang Zeng; Kim A Brogden
Journal:  Sci Rep       Date:  2019-07-26       Impact factor: 4.379

7.  Malignant and nonmalignant gene signatures in squamous head and neck cancer.

Authors:  Maria J Worsham; Mei Lu; Kang Mei Chen; Josena K Stephen; Shaleta Havard; Vanessa P Schweitzer
Journal:  J Oncol       Date:  2012-04-12       Impact factor: 4.375

8.  Tumor cells with low proteasome subunit expression predict overall survival in head and neck cancer patients.

Authors:  Chann Lagadec; Erina Vlashi; Sunita Bhuta; Chi Lai; Paul Mischel; Martin Werner; Michael Henke; Frank Pajonk
Journal:  BMC Cancer       Date:  2014-03-05       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.